Encyclopedia of Opinion
Question
Should there be advertisements for prescription drugs?
Position1 of 2›
No, there should not be advertisements for prescription drugs
Argument1 of 2›

Advertising prescription drugs in media trivializes their potential harm

If a medication with potentially deadly side effects is advertised in the same commercial break as a new candy, car insurance, or perhaps even children’s show, it implies that utilizing potentially harmful medications is as mundane and accessible as buying a six-pack at the store.

The argument

Advertising is created for the purpose of selling a product. The idea that direct-to-consumer advertising of prescription drugs is about anything other than sales is preposterous — advertising is not an educational format that happens to be paid for by manufacturers, it is a sales format, and it is designed by people whose task is to increase the number of units sold. The commercial history bears this out. DTC advertising did not begin until the 1980s and has since become a multibillion dollar industry, one that profits by convincing people that they may need a drug whether or not they actually do. An industry of that size is not sustained by informing the small number of people who genuinely need a given medicine; it is sustained by reaching everyone else. The damage is done by the company the advertisements keep. When drug commercials are shown alongside car commercials, yogurt commercials and every other kind, they are commodified — turned into just another solution to your problems, in the same way that the new car will make you happier and the yogurt will make you slimmer. The format itself carries a message about the product: that it is an ordinary consumer choice, evaluated by the viewer, available on request. That message is false in a way that matters. Prescription medications require a prescription for a reason. They can have seriously harmful side effects, which is precisely why they need to be discussed with and evaluated by a healthcare provider rather than selected from an advertisement. The gatekeeping is not an administrative obstacle; it is the mechanism by which the harm is avoided. To advertise these drugs as a quick and easy purchase is therefore dangerous to the well-being of all, because it trivialises exactly the risk the prescription requirement exists to manage.

Premises

[P1]Advertising exists to sell a product, and direct-to-consumer drug ads are a multibillion-dollar industry built on convincing people they need medications. [P2] Shown alongside car and yogurt commercials, drug ads commodify prescriptions into just another quick solution to one's problems. [P3] But prescriptions require a doctor's evaluation precisely because they can have seriously harmful side effects. [C] Therefore, because advertising prescription drugs in media trivializes their potential harm, there should not be advertisements for prescription drugs.

Counter-arguments

Just because something is advertised, doesn’t inherently make it bad or insidious. DTC works to aid consumers in learning about new medications that might help them with potential health conditions and to be able to discuss them as potential options with their healthcare provider. DTC equips patients to ask questions; it is not a mandate for patients to blindly consume medications.

Rejecting the premises

[Rejecting P1] That advertising exists to sell is true and does not settle the question, since advertising that sells can also inform. The premise treats a commercial motive as though it determined the effect, and the industry's size measures spending rather than harm. [Rejecting P2] The commodification claim is an aesthetic observation presented as evidence. Adjacency in a commercial break is a scheduling fact, and the argument needs a demonstration that viewers actually come to treat medicines as ordinary consumer goods, not an assertion that the format implies they will. [Rejecting P3] This is the strongest premise and it does not deliver the conclusion, because a prescriber still stands between the advertisement and the drug. The serious case against the practice runs through evidence the argument never uses — that advertising shifts prescribing toward newer and costlier drugs with shorter safety records, that patient requests raise prescribing rates, and that only two countries permit it at all — and it would still have to answer the counter's point that some campaigns bring undiagnosed patients into treatment.